Analysis on Clinical Characteristics and Influencing Factors of Patients with Locoregionally Advanced Nasopharyngeal Carcinoma |
Zheng, Wei
(Department of Radiation Oncology, Fujian Provincial Cancer Hospital)
Xu, Yuan-Ji (The Shengli Clinical Medical College of Fujian Medical University) Qiu, Su-Fang (Department of Radiation Oncology, Fujian Provincial Cancer Hospital) Zong, Jing-Feng (Department of Radiation Oncology, Fujian Provincial Cancer Hospital) Huang, Ling-Ling (The Shengli Clinical Medical College of Fujian Medical University) Huang, Chao-Bin (Department of Radiation Oncology, Fujian Provincial Cancer Hospital) Lin, Shao-Jun (Department of Radiation Oncology, Fujian Provincial Cancer Hospital) Pan, Jian-Ji (Department of Radiation Oncology, Fujian Provincial Cancer Hospital) |
1 | Chen JL, Huang YS, Kuo SH, et al (2013). Intensity-modulated radiation therapy for T4 nasopharygeal carcinoma. Strahlenther Onkol, 189, 1001-8. DOI |
2 | Demirci S, Kamer S, Kara G, et al (2011). Does the prognosis of nasopharyngeal cancer differ among endemic and nonendemic regions? Acta Otolaryngol, 131, 852-60. DOI |
3 | Dizman A, Coskun-Breuneval M, Altinisik-Inan G, et al (2014). Reirradiation with robotic stereotactic body radiotherapy for recurrent nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 15, 3561-6. DOI |
4 | Hu S, Du J, Li D, et al (2014). Mitochondrial DNA haplogroup confers genetic susceptibility to nasopharyngeal carcinoma in chaoshanese from guangdong, china. PLOS ONE, 9, 87795. DOI |
5 | Lee AW, Ng WT, Chan LLK, et al (2014).Evolution of treatment for nasopharyngeal cancer- Sucess and setback in the intensity-modulated radiotherapy era. Radiother Oncol, 110, 377-84. DOI |
6 | Li JX, Lu TX, Huang Y, et al (2012). Clinical characteristics of recurrent nasopharyngeal carcinoma in high-incidence area. Scientific World J, 2012, 719754. |
7 | Li K, Lin GZ, Shen JC, et al (2014). Time trends of nasopharyngeal carcinoma in urban Guangzhou over a 12-year period (2000- 2011): declines in both incidence and mortality. Asian Pac J Cancer Prev, 15, 9899-903. DOI |
8 | Lin S, Pan J, Han L, Zhang X, et al (2009). Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys, 75, 1071-8. DOI ScienceOn |
9 | Lin SJ, Pan JJ, Han L, et al (2014). Update report of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy and hypothesis of the optimal margin. Radiother Oncol, 110, 385-9. DOI |
10 | Qu S, Liang ZG, Zhu XD (2015). Advances and challenges in intensity-modulated radiotherapy for nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 16, 1687-92. DOI |
11 | Wang Y, Zhao H, Zhang ZQ, et al (2014). MR imaging prediction of local control of nasopharyngeal carcinoma treated with radiation therapy and chemotherapy. Br J Radiol, 87, 20130657. DOI |
12 | Wu F, Wang RS, Lu HM, et al (2014). Concurrent chemoradiotherapy in the locoregionally advanced nasopharyngeal carcinoma: Treatment outcomes of a prospective, multicentric clinical study. Radiother Oncol, 112, 106-11. DOI |
13 | Wu SY, Wu YH, Yang MW, et al (2014). Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5 year follow-up. Plos One, 14, 787. |
14 | Xu L, Pan J, Wu J, et al (2010). Factors associated with overall survival in 1706 patients with nasopharyngeal carcinoma: significance of intensive neoadjuvant chemotherapy and radiation break. Radiother Oncol, 96, 94-9. DOI |
15 | Zeng L, Tian YM, Sun XM, et al (2014). Intensity-modulated radiotherapy for stage IVA/IVB nasopharygeal carcinoma. Strahlenther Onkol, 190, 993-1000. DOI |